Loading clinical trials...
Loading clinical trials...
Conditions
Interventions
Psilocybin
Locations
1
United States
The University of Texas M. D. Anderson Cancer Center
Houston, Texas, United States
Start Date
May 23, 2025
Primary Completion Date
March 31, 2027
Completion Date
March 31, 2029
Last Updated
April 16, 2026
NCT05468034
NCT04541381
NCT07446322
NCT07489378
NCT06713993
NCT06594926
Lead Sponsor
M.D. Anderson Cancer Center
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions